A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

InP-PAM-(cycles 5-6) v1

Description
Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol in use. Please ensure
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

InPEtoposideIfosfamide(5dy)Ver1

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 day) Inpatient Regimen Regimen Sarcoma-InP-Etoposide-Ifosfamide (5 day) Indication Second line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPEtoposideIfosfamide5dyVer1.pdf

InP Ifosfamide(2day)Ver1

Description
Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day) Indication Advanced or metastatic soft tissue sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

InP Doxorubicin Etoposide Ifosfamide Vincristine VIDEVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-ETOPOSIDE-IFOSFAMIDE -VINCRISTINE (VIDE) Inpatient Regimen Regimen Sarcoma-InP- Doxorubicin-Etoposide-Ifosfamide-Vincristine (VIDE) Indication Ewings Sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinEtoposideIfosfamideVincristineVIDEVer1.pdf

InP Cyclophosphamide Doxorubicin Etoposide Vincristine VCDEVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-CYCLOPHOSPHAMIDE-ETOPOSIDE-VINCRISTINE (VCDE) Inpatient Regimen Regimen Sarcoma-InP- Cyclophosphamide-Doxorubicin-Etoposide-Vincristine (VCDE) Indication Rhabdommyosarcoma Toxicity
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPCyclophosphamideDoxorubicinEtoposideVincristineVCDEVer1.pdf

Doxorubicin-Olaratumab

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-OLARATUMAB Regimen • Sarcoma – Doxorubicin-Olaratumab Indication • In combination with doxorubicin for the first line treatment of advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Doxorubicin-Olaratumab.pdf

Docetaxel-Gemcitabine v1.2

Description
Chemotherapy Protocol SARCOMA DOCETAXEL-GEMCITABINE Regimen Sarcoma-Docetaxel-Gemcitabine Indication Relapsed metastatic osteosarcoma Selected metastatic soft tissue sarcomas (third line) / uterine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Docetaxel-Gemcitabinev1.2.pdf

Cyclophosphamide-Dactinomycin-Vincristine (VAC) v1

Description
Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-DACTINOMYCIN-VINCRISTINE (VAC) Regimen Sarcoma-Cyclophosphamide-Dactinomycin-Vincristine (VAC) Indication Ewings Sarcoma Toxicity Drug Cyclophosphamide Dactinomycin Vincristine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Dactinomycin-Vincristine-VAC-v1.pdf

Z-DEX dexamethasone idarubicin ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA Z-DEX-DEXAMETHASONE-IDARUBICIN Regimen Multiple Myeloma – Z-DEX-Dexamethasone-Idarubicin Indication First or subsequent line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Z-DEX-dexamethasone-idarubicin-ver1.pdf

MyelomaPAD-Bortezomib(SC)DexamethasoneDoxorubicinVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA PAD (SC)-BORTEZOMIB (SC)-DEXAMETHASONE-DOXORUBICIN Regimen Multiple Myeloma – PAD (SC)-Bortezomib (SC)-Dexamethasone-Doxorubicin Indication Second
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaPAD-BortezomibSCDexamethasoneDoxorubicinVer1.pdf
751 to 760 of 1000
Previous … 74 75 76 77 78 … Next